ArticleGene therapy2023

Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response.

Tábata Almeida Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.